We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Stronger warnings about the risk of dependence and addiction to be added to the patient information leaflet and discussed with patients
The MHRA will now issue all safety-critical alerts for medicines and medical devices that require action as National Patient Safety Alerts
Reporting suspected side effects or incidents to the Yellow Card scheme supports the safe use of medical products for everyone
Stephen Lightfoot will become Chair of the Medicines and Healthcare products Regulatory Agency (MHRA) from 1 September 2020.
People who take stimulant laxatives for constipation are being advised that these will now be sold in smaller packs, with on-pack warnings.
Pharmaceutical and biotech organisation Wockhardt will carry out the crucial 'fill and finish' stage of the vaccine manufacturing process.
First published during the 2019 to 2022 Johnson Conservative government
A new campaign to raise awareness of the fire risk and the precautions that need to be taken by users of skin creams has been launched today
Ground-breaking innovation to support medical technologies
Deal announced which will secure early access to a promising new coronavirus vaccine, enhancing the UK’s growing portfolio of vaccine candidates.
The MHRA is aware of certificates being issued by certification bodies headed “certificates of compliance” or “Attestation of Compliance”.
The UK has secured early access to 90 million doses of promising coronavirus vaccine candidates.
The CMA has formally concluded that 3 pharmaceutical companies took part in an illegal arrangement in relation to the supply of life-saving medicine.
Today’s publication of the Independent Medicines and Medical Devices Safety Review is of profound importance for the MHRA, since the safety of the public is our first priority.
Warning that thermal cameras and other such “temperature screening” products, some of which make direct claims to screen for COVID-19, are not a reliable way to detect if people have the virus.
Recent media reports have suggested that chloroquine can protect patients from coronavirus or treat COVID-19, the illness caused by a coronavirus.
The MHRA has approved the recruitment of further participants for a clinical trial by the University of Oxford
The health minister's letter thanks directors of public health and their teams for their response to COVID-19 so far.
The Medicines and Healthcare products Regulatory Agency (MHRA) has instructed UK clinical trialists using hydroxychloroquine to treat or prevent coronavirus (COVID-19) to suspend recruitment of further participants.
A convicted fugitive faces the confiscation of £1.4 million in prime assets by the Crown, following a hearing at Southwark Crown Court today.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).